Drugs / SARS-CoV-2 non-immune Plasma
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04323800 Comparator | Jun 2020 → Apr 2021 | Coronaviridae infectious disease | Johns Hopkins University | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SARS-CoV-2 non-immune Plasma | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04323800 ↗ |